Suchergebnisse - "Huang, Chiun-Sheng"

PubPharm (372)

31

Comparing Genetic Risk and Clinical Risk Classification in Luminal-like Breast Cancer Patients Using a 23-Gene Classifier

enthalten in: Cancers | 2022

von Huang, C. | Chen, T. | Liu, L. | +7

32

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer : Primary results from PALOMA-4

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Xu, B. | Hu, X. | Li, W. | +15

33

Prognostic Comparison between Oncotype DX® and a 23-Gene Classifier, RecurIndex®, on the Taiwan Breast Cancer Population

enthalten in: Diagnostics (Basel, Switzerland) | 2022

von Chang, C. | Yang, P. | Hsieh, C. | +4

34

GLORIA : phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer

enthalten in: Future oncology (London, England) | 2022

von Rugo, H. | Cortes, J. | Barrios, C. | +9

35

Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

enthalten in: NPJ breast cancer | 2022

von Loibl, S. | Huang, C. | Mano, M. | +16

36

Circulating tumor DNA as a predictive marker of recurrence for patients with stage II-III breast cancer treated with neoadjuvant therapy

enthalten in: ResearchSquare.com | 2022

von Lin, P. | Wang, M. | Lo, C. | +9

37

The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von Hung, J. | Chen, I. | Ueng, S. | +8

38

Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2) : an open-label, multicenter, phase II trial

enthalten in: Breast cancer research and treatment | 2022

von Hickish, T. | Mehta, A. | Liu, M. | +11

39

Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients

enthalten in: Breast cancer research and treatment | 2022

von Lin, P. | Chen, S. | Tseng, L. | +19

40

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Cortés, J. | Kim, S. | Chung, W. | +122

CommentIn: Nat Rev Clin Oncol. 2022 May;19(5):283. - PMID 35361895